The DOI matches its Crossref record; 29 of the 30 references it cites were found in a registry or an index.
Dynamics of gene expression for a hippocampal glycoprotein elevated in Alzheimer's disease and in response to experimental lesions in rat
Abstract
A hippocampal poly(A) RNA, pADHC-9, was cloned by differential screening of a human hippocampal cDNA library. By RNA blot analysis, pADHC-9 was elevated 2-fold in Alzheimer's disease hippocampus. In situ analyses identified pADHC-9 expression in pyramidal and non-pyramidal cells of the hippocampus and entorhinal cortex. Nucleotide sequence analysis identified pADHC-9 as a potential human homolog of rat sulfated glycoprotein 2 (SGP-2). SGP-2 expression increased in rat hippocampus following experimental lesions that mimic intrinsic neuronal loss and/or deafferentation. The function of pADHC-9 in brain has not been defined, but in serum, a similar protein inhibits complement-dependent cytolysis. Increased expression of pADHC-9 in Alzheimer's disease hippocampus may be a compensatory response mounted to retard a complement-driven neurodegenerative cascade.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“CLU was first associated with Alzheimer’s disease (AD) in 1990 when it was found to be increased in the hippocampi of AD patients (May, et al., 1990)”
From A potential endophenotype for Alzheimer's disease: cerebrospinal fluid clusterin (2016) · cites this paper as May, et al., 1990
Citations
Cites
Molecular Cloning: A Laboratory Manual
Sambrook, J., Fritsch, E., & Maniatis, T. (1989) · UCLA - Biblioteca de Ciencias de la Salud · Cited by 133,589
A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity
Feinberg, A. P., & Vogelstein, B. (1983) · Analytical Biochemistry · doi:10.1016/0003-2697(83)90418-9 · Cited by 24,512
Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease
Chirgwin, J. M., Przybyla, A., MacDonald, R. J., & Rutter, W. J. (1979) · Biochemistry · doi:10.1021/bi00591a005 · Cited by 21,725
A simple and very efficient method for generating cDNA libraries
Gubler, U., & Hoffman, B. J. (1983) · Gene · doi:10.1016/0378-1119(83)90230-5 · Cited by 4,461
Alzheimer's disease: cell-specific pathology isolates the hippocampal formation.
Hyman, B. T., Van Hoesen, G. W., Damasio, A. R., & Barnes, C. L. (1984) · Science · doi:10.1126/science.6474172 · Cited by 2,268
Intraventricular kainic acid preferentially destroys hippocampal pyramidal cells
Nadler, J. V., Perry, B. W., & Cotman, C. W. (1978) · Nature · doi:10.1038/271676a0 · Cited by 745
Rogers, J., Luber-Narod, J., Styren, S. D., & Civin, W. H. (1988) · Neurobiology of Aging · doi:10.1016/s0197-4580(88)80079-4 · Cited by 743
Perforant pathway changes and the memory impairment of Alzheimer's disease
Hyman, B. T., Van Hoesen, G. W., Kromer, L. J., & Damasio, A. R. (1986) · Annals of Neurology · doi:10.1002/ana.410200406 · Cited by 672
Developmentally regulated expression of specific tau sequences
Kosik, K. S., Orecchio, L. D., Bakalis, S., & Neve, R. L. (1989) · Neuron · doi:10.1016/0896-6273(89)90077-9 · Cited by 598
Plasticity of Hippocampal Circuitry in Alzheimer's Disease
Geddes, J. W., Monaghan, D. T., Cotman, C. W., Lott, I. T., Kim, R. C., & Chui, H. C. (1985) · Science · doi:10.1126/science.4071042 · Cited by 461
Cited by
Sorted by citations
Items 101–200 of 339
Lipid Metabolism and Glial Lipoproteins in the Central Nervous System
Hayashi, H. (2011) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.34.453 · Cited by 80
Kida, E., Choi-Miura, N.-H., & Wisniewski, K. E. (1995) · Brain Research · doi:10.1016/0006-8993(95)00482-6 · Cited by 79
BACE2, a conditional β-secretase, contributes to Alzheimer’s disease pathogenesis
Wang, Z., Xu, Q., Cai, F., Liu, X., Wu, Y., & Song, W. (2019) · JCI Insight · doi:10.1172/jci.insight.123431 · Cited by 82
The extracellular chaperone Clusterin enhances Tau aggregate seeding in a cellular model
Yuste‐Checa, P., Trinkaus, V. A., Riera-Tur, I., Imamoglu, R., Schaller, T., Wang, H., Dudanova, I., Hipp, M. S., Bracher, A., & Hartl, F. U. (2021) · Nature Communications · doi:10.1038/s41467-021-25060-1 · Cited by 78
Roles of the Complement System in Human Neurodegenerative Disorders
Gasque, P., Neal, J. W., Singhrao, S. K., McGreal, E. P., Dean, Y. D., van Beek, J., & Morgan, B. P. (2002) · Molecular Neurobiology · doi:10.1385/mn:25:1:001 · Cited by 77
Genetics of Clusterin Isoform Expression and Alzheimer's Disease Risk
Ling, I., Bhongsatiern, J., Simpson, J. F., Fardo, D. W., & Estus, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033923 · Cited by 76
Cholesterol-related genes in Alzheimer's disease
Wollmer, M. A. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2010.05.009 · Cited by 78
Kida, E., Pluta, R. M., Lossinsky, A. S., Golabek, A. A., Choi-Miura, N.-H., Wisniewski, H. M., & Mossakowski, M. J. (1995) · Brain Research · doi:10.1016/0006-8993(94)01467-v · Cited by 76
Morgan, T. E., Laping, N. J., Rozovsky, I., Oda, T., Hogan, T. H., Finch, C. E., & Pasinetti, G. M. (1995) · Journal of Neuroimmunology · doi:10.1016/0165-5728(94)00194-s · Cited by 75
Self-citationMichel, D., Chabot, J., Moyse, E., Danik, M., & Quirion, R. (1992) · Synapse · doi:10.1002/syn.890110203 · Cited by 76
McNeill, T. H., Masters, J. N., & Finch, C. E. (1991) · Experimental Neurology · doi:10.1016/0014-4886(91)90062-h · Cited by 74
Self-citationClusterin Levels in Plasma Predict Cognitive Decline and Progression to Alzheimer’s Disease
Jongbloed, W., van Dijk, K. D., Mulder, S. D., van de Berg, W. D. J., Blankenstein, M. A., van der Flier, W. M., & Veerhuis, R. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150036 · Cited by 74
Multiple Involvement of Clusterin in Chicken Ovarian Follicle Development
Mahon, M. G., Lindstedt, K. A., Hermann, M., Nimpf, J., & Schneider, W. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.7.4036 · Cited by 72
Martiskainen, H., Viswanathan, J., Nykänen, N.-P., Kurki, M., Helisalmi, S., Natunen, T., Sarajärvi, T., Kurkinen, K. M. A., Pursiheimo, J.-P., Rauramaa, T., et al. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.09.003 · Cited by 70
Gp80 (clusterin; TRPM-2) mRNA level is enhanced in human renal clear cell carcinomas
Parczyk, K., Pilarsky, C. P., Rachel, U., & Koch-Brandt, C. (1994) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/bf01202200 · Cited by 70
Isolation and Characterization of Apolipoproteins from Murine Microglia
Xu, Q., Li, Y., Cyras, C., Sanan, D. A., & Cordell, B. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002796200 · Cited by 69
The Immunopathology of Alzheimer's Disease and Some Related Disorders
Kalaria, R. N. (1993) · Brain Pathology · doi:10.1111/j.1750-3639.1993.tb00761.x · Cited by 69
Shanmugaratnam, J., Berg, E., Kimerer, L., Johnson, R. J., Amaratunga, A., Schreiber, B. M., & Fine, R. E. (1997) · Molecular Brain Research · doi:10.1016/s0169-328x(97)00176-9 · Cited by 68
(1993) · PubMed Central · Cited by 68
French, L. E., Sappino, A. P., Tschopp, J., & Schifferli, J. A. (1992) · Journal of Clinical Investigation · doi:10.1172/jci116069 · Cited by 68
Roles of Extracellular Chaperones in Amyloidosis
Wyatt, A. R., Yerbury, J. J., Dabbs, R. A., & Wilson, M. R. (2012) · Journal of Molecular Biology · doi:10.1016/j.jmb.2012.01.004 · Cited by 67
Han, S.-H., Park, J.-C., & Mook-Jung, I. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.12.004 · Cited by 67
Cheng, H. W., Jiang, T., Brown, S. A., Pasinetti, G. M., Finch, C. E., & McNeill, T. H. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90377-8 · Cited by 65
Self-citationA potential endophenotype for Alzheimer's disease: cerebrospinal fluid clusterin
Deming, Y., Xia, J., Cai, Y., Lord, J., Holmans, P., Bertelsen, S., Holtzman, D., Morris, J. C., Bales, K., Pickering, E. H., et al. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.09.009 · Cited by 66
Melloni, R. H., Apostolides, P. J., Hamos, J. E., & DeGennaro, L. J. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90448-0 · Cited by 66
Zellweger, T., Kiyama, S., Chi, K. N., Miyake, H., Adomat, H. H., Skov, K. A., & Gleave, M. E. (2003) · British Journal of Urology · doi:10.1046/j.1464-410x.2003.04349.x · Cited by 64
Depletion of clusterin in renal diseases causing nephrotic syndrome
Ghiggeri, G. M., Bruschi, M., Candiano, G., Rastaldi, M. P., Scolari, F., Passerini, P., Musante, L., Pertica, N., Caridi, G., Ferrario, F., et al. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00664.x · Cited by 64
Barnum, S. R., Jones, J. L., Müller-Ladner, U., Samimi, A., & Campbell, I. L. (1996) · Glia · doi:10.1002/(sici)1098-1136(199610)18:2 · Cited by 63
Nitsch, R., & Frotscher, M. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.11.5197 · Cited by 64
Nuutinen, T., Suuronen, T., Kauppinen, A., & Salminen, A. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.03.041 · Cited by 63
Clusterin in Alzheimer's disease
Wu, Z., Yu, J., Li, Y., & Tan, L. (2012) · Advances in clinical chemistry · doi:10.1016/b978-0-12-394317-0.00011-x · Cited by 63
Tycko, B., Feng, L., Nguyen, L., Francis, A., Hays, A., Chung, W.-Y., Tang, M.-X., Stern, Y., Sahota, A., Hendrie, H., et al. (1996) · Human Genetics · doi:10.1007/s004390050234 · Cited by 61
Zetzsche, T., Rujescu, D., Hardy, J., & Hampel, H. J. (2010) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.10.48 · Cited by 63
Alterations in cholesterol metabolism–related genes in sporadic Alzheimer's disease
Picard, C., Julien, C., Frappier, J., Miron, J., Théroux, L., Dea, D., Breitner, J. C. S., & Poirier, J. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.01.018 · Cited by 60
Self-citationClusterin: an enigmatic protein recruited by diverse stimuli.
Rosenberg, M. E., Dvergsten, J., & Correa‐Rotter, R. (1993) · PubMed · Cited by 59
Clusterin contributes to early stage of Alzheimer's disease pathogenesis
Oh, S., Kim, M. S., Park, S., Son, H., Kim, S., Kim, M., Jo, D., Tak, E., & Lee, J. (2018) · Brain Pathology · doi:10.1111/bpa.12660 · Cited by 59
HDL Proteome and Alzheimer’s Disease: Evidence of a Link
Marsillach, J., Adorni, M. P., Zimetti, F., Papotti, B., Zuliani, G., & Cervellati, C. (2020) · Antioxidants · doi:10.3390/antiox9121224 · Cited by 62
Semaphorin D acts as a repulsive factor for entorhinal and hippocampal neurons
Steup, A., Ninnemann, O., Savaskan, N. E., Püschel, R. N. A. W., & Skutella, T. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00517.x · Cited by 58
Genetic Variability in CLU and Its Association with Alzheimer's Disease
Guerreiro, R. J., Beck, J., Gibbs, J. R., Santana, I. J., Rossor, M. N., Schott, J. M., Nalls, M. A., Ribeiro, H. F., Santiago, B., Fox, N. C., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009510 · Cited by 57
Complement proteins and complement inhibitors in Alzheimer's disease
McGeer, P. L., & McGeer, E. G. (1992) · Research in Immunology · doi:10.1016/0923-2494(92)80045-m · Cited by 57
Toxicity mediated by soluble oligomers of β‐amyloid(1–42) on cholinergic SN56.B5.G4 cells
Heinitz, K., Beck, M., Schliebs, R., & Perez-Polo, J. R. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04015.x · Cited by 58
Svensson, M. A., Liu, L., Mattsson, P., Morgan, B. P., & Aldskogius, H. (1995) · Molecular and Chemical Neuropathology · doi:10.1007/bf03160112 · Cited by 56
Traumatic brain injury induces biphasic upregulation of ApoE and ApoJ protein in rats
Iwata, A., Browne, K. D., Chen, X., Yuguchi, T., & Smith, D. H. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20607 · Cited by 53
Pasinetti, G. M., & Finch, C. E. (1991) · Neuroscience Letters · doi:10.1016/0304-3940(91)90213-d · Cited by 55
Self-citationClusterin Is Required for β-Amyloid Toxicity in Human iPSC-Derived Neurons
Robbins, J. P., Perfect, L., Ribé, E. M., Maresca, M., Dangla-Valls, A., Foster, E. M., Killick, R., Nowosiad, P., Reid, M. J., Polit, L. D., et al. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00504 · Cited by 53
Clusterin accumulates in dying neurons following status epilepticus
Dragunow, M., Preston, K., Dodd, J. R., Young, D., Lawlor, P. A., & Christie, D. L. (1995) · Molecular Brain Research · doi:10.1016/0169-328x(95)00088-a · Cited by 54
Laping, N. J., Nichols, N. R., Day, J. R., & Finch, C. E. (1991) · Molecular Brain Research · doi:10.1016/0169-328x(91)90087-e · Cited by 54
Self-citationApolipoprotein J (clusterin) activates rodent microglia in vivo and in vitro
Xie, Z., Harris‐White, M. E., Wals, P. A., Frautschy, S. A., Finch, C. E., & Morgan, T. E. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03065.x · Cited by 53
Self-citationRelationship Between Multifunctional Protein "Clusterin" and Alzheimer Disease
Choi-Miura, N.-H., & Oda, T. (1996) · Neurobiology of Aging · doi:10.1016/0197-4580(96)00106-6 · Cited by 54
Major, D. E., Kesslak, J. P., Cotman, C. W., Finch, C. E., & Day, J. R. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00102-4 · Cited by 52
Self-citationLish, A. M., Grogan, E. F. L., Benoit, C. R., Pearse, R. V., Heuer, S. E., Luquez, T., Orme, G. A., Galle, P. C., Milinkeviciute, G., Green, K. N., et al. (2025) · Neuron · doi:10.1016/j.neuron.2025.03.034 · Cited by 55
Clusterin levels increase during neuronal development
O’Bryan, M. K., Cheema, S. S., Bartlett, P. F., Murphy, B. F., & Pearse, M. J. (1993) · Journal of Neurobiology · doi:10.1002/neu.480240402 · Cited by 51
Molecular and cellular mediators of Alzheimer's disease inflammation
Strohmeyer, R., & Rogers, J. (2001) · Journal of Alzheimer s Disease · doi:10.3233/jad-2001-3118 · Cited by 52
The role of clusterin in tissue injury
Silkensen, J. R., Schwochau, G. B., & Rosenberg, M. E. (1994) · Biochemistry and Cell Biology · doi:10.1139/o94-065 · Cited by 50
Complement-mediated neurotoxicity is regulated by homologous restriction
Shen, Y., Halperin, J. A., & Lee, C. (1995) · Brain Research · doi:10.1016/0006-8993(94)01264-i · Cited by 50
Sulfated glycoprotein-2 is increased in rat hippocampus following entorhinal cortex lesioning
Lampert-Etchells, M., McNeill, T. H., Laping, N. J., Zarow, C., Finch, C. E., & May, P. C. (1991) · Brain Research · doi:10.1016/0006-8993(91)91520-b · Cited by 50
Self-citationGraphene FET Sensors for Alzheimer’s Disease Protein Biomarker Clusterin Detection
Bungon, T., Haslam, C., Damiati, S., O’Driscoll, B., Whitley, T., Davey, P., Siligardi, G., Charmet, J., & Awan, S. A. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.651232 · Cited by 49
Smyth, M. D., Cribbs, D. H., Tenner, A. J., Shankle, W. R., Dick, M. B., Kesslak, J. P., & Cotman, C. W. (1994) · Neurobiology of Aging · doi:10.1016/0197-4580(94)00055-7 · Cited by 49
de Lecea, L., Soriano, E., Criado, J., Steffensen, S. C., Henriksen, S. J., & Sutcliffe, J. G. (1994) · Molecular Brain Research · doi:10.1016/0169-328x(94)90164-3 · Cited by 49
Co-deposition of clusterin with the complement membrane attack complex in myocardial infarction.
Väkevä, A., Laurila, P., & Meri, S. (1993) · PubMed Central · Cited by 48
Protein Homeostasis at the Plasma Membrane
Apaja, P. M., & Lukács, G. L. (2014) · Physiology · doi:10.1152/physiol.00058.2013 · Cited by 46
Reversible Inactivation of Superoxide‐Sensitive Aconitase in Aβ1‐42‐Treated Neuronal Cell Lines
Longo, V. D., Viola, K. L., Klein, W. L., & Finch, C. E. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0751977.x · Cited by 46
Self-citationExpression of the complement membrane attack complex and its inhibitors in Pick disease brain
Yasuhara, O., Aimi, Y., McGeer, E. G., & McGeer, P. L. (1994) · Brain Research · doi:10.1016/0006-8993(94)90246-1 · Cited by 46
Association cortex, cerebellum, and serum concentrations of C1q and factor B in Alzheimer's disease
Brachova, L., Lue, L., Schultz, J. J., Rashidy, T. E., & Rogers, J. (1993) · Molecular Brain Research · doi:10.1016/0169-328x(93)90097-9 · Cited by 46
Alzheimer’s Disease: From Genetic Variants to the Distinct Pathological Mechanisms
Sun, Q., Xie, N., Tang, B., Li, R., & Shen, Y. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00319 · Cited by 46
Sulfated glycoprotein-2 expression increases in rodent brain after transient global ischemia
May, P. C., Robison, P. M., Fuson, K. S., Smalstig, B., Stephenson, D. T., & Clemens, J. A. (1992) · Molecular Brain Research · doi:10.1016/0169-328x(92)90148-5 · Cited by 46
Self-citationFunction and Comorbidities of Apolipoprotein E in Alzheimer′s Disease
Leduc, V., Domenger, D., Beaumont, L. D., Lalonde, D., Jasmin, S. B., & Poirier, J. (2011) · International Journal of Alzheimer s Disease · doi:10.4061/2011/974361 · Cited by 46
Self-citationMicroglia and Aging in the Brain
Finch, C. E., Morgan, T. E., Rozovsky, I., Xie, Z., Weindruch, R. H., & Prolla, T. A. (2002) · Springer eBooks · doi:10.1007/978-1-4757-4139-1_13 · Cited by 43
Self-citationHuman megakaryocytes express clusterin and package it without apolipoprotein A-1 into alpha-granules
Tschopp, J. F., Jenne, D., Hertig, S., Preissner, K., Morgenstern, H., Sapino, A., & French, L. E. (1993) · Blood · doi:10.1182/blood.v82.1.118.bloodjournal821118 · Cited by 44
State of Play in Alzheimer’s Disease Genetics
Zhu, J.-B., Tan, C., Tan, L., & Yu, J. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170062 · Cited by 44
Raikwar, S. P., Kikkeri, N. S., Sakuru, R. C., Saeed, D., Zahoor, H., Premkumar, K., Mentor, S., Thangavel, R., Dubova, I., Ahmed, M. E., et al. (2019) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-019-09849-y · Cited by 48
Clusterin Prevents Aggregation of Neuropeptide 106-126 in Vitro
McHattie, S., & Edington, N. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0781 · Cited by 43
Clusterin induces differentiation of pancreatic duct cells into insulin-secreting cells
Kim, B. M., Kim, S. Y., Lee, S., Shin, Y. J., Min, B., Bendayan, M., & Park, I.-S. (2006) · Diabetologia · doi:10.1007/s00125-005-0106-2 · Cited by 43
Clusterin expression in differentiating smooth muscle cells.
Thomas-Salgar, S., & Millis, A. J. T. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32391-8 · Cited by 43
Cai, R., Han, J., Sun, J. L., Huang, R., Tian, S., Shen, Y., Dong, X., Xia, W., & Wang, S. (2016) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2016.00179 · Cited by 45
Effects of Age on Gene Expression during Estrogen-Induced Synaptic Sprouting in the Female Rat
Stone, D. J., Rozovsky, I., Morgan, T. E., Anderson, C. P., Lopez, L. M., Shick, J., & Finch, C. E. (2000) · Experimental Neurology · doi:10.1006/exnr.2000.7455 · Cited by 42
Self-citationInjury‐induced Synthesis and Release of Apolipoprotein E and Clusterin from Rat Neural Cells
Messmer, S., Sagot, Y., Mattenberger, L., James, R. W., & Kato, A. C. (1996) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1996.tb01560.x · Cited by 40
Gupta, V. B., Doecke, J. D., Hone, E., Pedrini, S., Laws, S. M., Thambisetty, M., Bush, A. I., Rowe, C. C., Villemagne, V. L., Ames, D. J., et al. (2015) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2015.12.001 · Cited by 39
The Role of Apolipoprotein E Isoforms in Alzheimer’s Disease
Roda, A. R., Montoliu‐Gaya, L., & Villegas, S. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-180740 · Cited by 41
Mulcrone, J. (1995) · Schizophrenia Research · doi:10.1016/0920-9964(94)00040-f · Cited by 40
Polihronis, M., Paizis, K., Carter, G., Sedal, L., & Murphy, B. (1993) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(93)90230-v · Cited by 39
Ho, S., Leav, I., Ghatak, S., Merk, F. B., Jagannathan, V. S., & Mallery, K. (1998) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65553-8 · Cited by 39
Structure and stability of apolipoprotein J-containing high-density lipoproteins
Stuart, W. D., Krol, B. J., Jenkins, S. H., & Harmony, J. A. K. (1992) · Biochemistry · doi:10.1021/bi00151a024 · Cited by 38
Glycosylation of Human Plasma Clusterin Yields a Novel Candidate Biomarker of Alzheimer’s Disease
Liang, H., Russell, C., Mitra, V., Chung, R., Hye, A., Bazenet, C. E., Lovestone, S., Pike, I., & Ward, M. A. (2015) · Journal of Proteome Research · doi:10.1021/acs.jproteome.5b00892 · Cited by 36
Cerebrospinal fluid and plasma clusterin levels in Parkinson's disease
van Dijk, K. D., Jongbloed, W., Heijst, J. A., Teunissen, C. E., Groenewegen, H. J., Berendse, H. W., van de Berg, W. D. J., & Veerhuis, R. (2013) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2013.07.016 · Cited by 37
Genetic underpinnings in Alzheimer’s disease – a review
Moustafa, A. A., Hassan, M., Hewedi, D. H., Hewedi, I. H., Garami, J. K., Alashwal, H., Zaki, N., Seo, S., Cutsuridis, V., Angulo, S. L., et al. (2017) · Reviews in the Neurosciences · doi:10.1515/revneuro-2017-0036 · Cited by 37
Molecular Neurobiology of Alzheimer's Disease (Syndrome?)
Zubenko, G. S. (1997) · Harvard Review of Psychiatry · doi:10.3109/10673229709000303 · Cited by 37
Astrocytic messenger RNA responses to striatal deafferentation in male rat
Pasinetti, G. M., Cheng, H. W., Morgan, D., Lampert-Etchells, M., McNeill, T. H., & Finch, C. E. (1993) · Neuroscience · doi:10.1016/0306-4522(93)90298-t · Cited by 38
Self-citationSteward, O. (1995) · The Journal of Comparative Neurology · doi:10.1002/cne.903590304 · Cited by 36
Michel, D., Moyse, E., Trembleau, A., Jourdan, F., & Brun, G. (1997) · Journal of Cell Science · doi:10.1242/jcs.110.14.1635 · Cited by 36
Söderberg, L., Kakuyama, H., Möller, A., Itô, A., Winblad, B. G., Tjernberg, L. O., & Näslund, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403628200 · Cited by 36
da Costa, G., Ribeiro-Silva, C., Mesquita-Ribeiro, R., Gilberto, S., Gomes, R. A., Ferreira, A. E. N., Mateus, É., Barroso, E., Coelho, A. V., Freire, A. P., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0125392 · Cited by 34
Mass spectrometry quantification of clusterin in the human brain
Chen, J., Wang, M., & Turko, I. V. (2012) · Molecular Neurodegeneration · doi:10.1186/1750-1326-7-41 · Cited by 33
Inflammatory mechanisms and anti-inflammatory therapy in Alzheimer's disease
O’Banion, M. K., & Finch, C. E. (1996) · Neurobiology of Aging · doi:10.1016/0197-4580(96)00102-9 · Cited by 33
Self-citationGenetic variation in Clusterin gene and Alzheimer's disease risk in Han Chinese
Yu, J., Ma, X., Wang, Y., Sun, L., Tan, L., Hu, N., & Tan, L. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.01.010 · Cited by 34
Genetic and biochemical markers for Alzheimer's disease: recent developments
Mulder, C., Scheltens, P., Visser, J. J., van Kamp, G. J., & Schutgens, R. B. H. (2000) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/0004563001899898 · Cited by 32
Lidström, A.-M., Hesse, C., Rosengren, L., Fredman, P., Davidsson, P., & Blennow, K. (2001) · Journal of Alzheimer s Disease · doi:10.3233/jad-2001-3501 · Cited by 32
Colacino, J. M., Malcolm, S. K., & Jaskunas, S. R. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.9.1997 · Cited by 32
Liu, Z., Chao, J., Wang, C., Sun, G., Roeth, D., Liu, W., Chen, X., Li, L., Tian, E., Feng, L., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112841 · Cited by 30
Sherva, R., & Farrer, L. A. (2011) · Current Psychiatry Reports · doi:10.1007/s11920-011-0184-4 · Cited by 31
Metadata
- Authors
- May, P. C., Lampert-Etchells, M., Johnson, S. A., Poirier, J., Masters, J. N., & Finch, C. E.
- Affiliations
- University of Southern California (US)
- Venue
- Neuron
- Publisher
- Elsevier BV
- Published
- 1990-12
- Volume
- 5
- Issue
- 6
- Pages
- 831-839
- ISSN
- 0896-6273 (ISSN-L)
- OpenAlex
- W2004102314
- Cited by
- 339
- References
- 30
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 7 · 2023: 5 · 2022: 4 · 2021: 7 · 2020: 6 · 2019: 10 · 2018: 8 · 2017: 7 · 2016: 9 · 2015: 10 · 2014: 11 · 2013: 10 · 2012: 12
- FWCI
- 15.87
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Neuron (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (AG 05142, P50AG005142)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Alzheimer's disease, hippocampus, gene expression, sulfated glycoprotein-2, polyadenylated RNA, entorhinal cortex, experimental brain lesions, deafferentation, neuronal loss, complement-dependent cytotoxicity, neurodegeneration, compensatory response
- MeSH terms
- Alzheimer Disease, Autoradiography, Cloning, Molecular, Denervation, DNA, Glycoproteins, Hippocampus, Humans, Male, Nucleic Acid Hybridization, RNA, Transcription, Genetic, DNA Probes, Gene Expression, Molecular Chaperones, Clusterin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review